Detalles de la búsqueda
1.
Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model: A Randomized, Double-Blind, Placebo-Controlled Trial.
Clin Infect Dis
; 66(9): 1435-1441, 2018 04 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-29145631
2.
Cohort profile of a US military population for evaluating pre-disease and disease serological biomarkers in rheumatoid and reactive arthritis: Rationale, organization, design, and baseline characteristics.
Contemp Clin Trials Commun
; 17: 100522, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31989058
3.
Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21.
mSphere
; 4(3)2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31043512
4.
Evaluation of a conjugate vaccine platform against enterotoxigenic Escherichia coli (ETEC), Campylobacter jejuni and Shigella.
Vaccine
; 36(45): 6695-6702, 2018 10 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30269917
5.
Erratum for Ramakrishnan et al., "Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21".
mSphere
; 4(3)2019 Jun 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31243083
6.
Correction for Ramakrishnan et al., "Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21".
mSphere
; 4(3)2019 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31118306
Resultados
1 -
6
de 6
1
Próxima >
>>